21
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?: A discussion based on recent recommendations from the European agency for evaluation of medicinal products regarding third generation oral contraceptive pills

, , &
Pages 482-490 | Published online: 07 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (22)

Giovanni Grandi, Maria Chiara Del Savio & Fabio Facchinetti. (2021) The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Review of Clinical Pharmacology 14:2, pages 211-224.
Read now
Giovanni Grandi, Fabio Barra, Simone Ferrero & Fabio Facchinetti. (2019) Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism 14:3, pages 153-155.
Read now
Ingrid Duijkers, Christine Klipping, Doris Heger-Mahn, Ghassan N. Fayad, Tara L. Frenkl, Sandra M. Cruz & Tjeerd Korver. (2018) Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing. The European Journal of Contraception & Reproductive Health Care 23:4, pages 245-254.
Read now
Chao Zhang, Haiyan Li, Xin Xiong, Suodi Zhai, Yudong Wei, Shuang Zhang, Yuanyuan Zhang, Lin Xu & Li Liu. (2017) An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch. Drug Design, Development and Therapy 11, pages 725-731.
Read now
Sumika Matsui, Toshiyuki Yasui, Kana Kasai, Kaoru Keyama, Kanako Yoshida, Takeshi Kato, Hirokazu Uemura, Akira Kuwahara, Toshiya Matsuzaki & Minoru Irahara. (2017) Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol. Journal of Obstetrics and Gynaecology 37:5, pages 627-632.
Read now
Justine Hugon-Rodin, Martine Alhenc-Gelas, H. Coenraad Hemker, Sylvie Brailly-Tabard, Anne Guiochon-Mantel, Geneviève Plu-Bureau & Pierre-Yves Scarabin. (2017) Sex hormone-binding globulin and thrombin generation in women using hormonal contraception. Biomarkers 22:1, pages 81-85.
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Marie Mawet, Catherine Maillard, Christine Klipping, Yvette Zimmerman, Jean-Michel Foidart & Herjan J.T. Coelingh Bennink. (2015) Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. The European Journal of Contraception & Reproductive Health Care 20:6, pages 463-475.
Read now
Iñaki Lete, Nathalie Chabbert-Buffet, Christian Jamin, Stefano Lello, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2015) Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. The European Journal of Contraception & Reproductive Health Care 20:5, pages 329-343.
Read now
Øjvind Lidegaard. (2014) Hormonal contraception, thrombosis and age. Expert Opinion on Drug Safety 13:10, pages 1353-1360.
Read now
Rossella E. Nappi, Anna Maria Paoletti, Annibale Volpe, Luca Chiovato, Brandon Howard, Herman Weiss & Nancy Ricciotti. (2014) Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women. The European Journal of Contraception & Reproductive Health Care 19:4, pages 285-294.
Read now
Yvette Zimmerman, Herjan J. T. Coelingh Bennink, Wout Wouters, Frieda Ebes & Bart C. J. M. Fauser. (2013) The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive. The European Journal of Contraception & Reproductive Health Care 18:6, pages 489-500.
Read now
Nathalie Chabbert-Buffet, Jan Gerris, Christian Jamin, Stefano Lello, Inaki Lete, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2013) Toward a new concept of “natural balance” in oral estroprogestin contraception. Gynecological Endocrinology 29:10, pages 891-896.
Read now
Yvette Zimmerman, Wout Wouters & Herjan J. T. Coelingh Bennink. (2013) The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone. The European Journal of Contraception & Reproductive Health Care 18:3, pages 206-214.
Read now
Ulla M. Ågren, Marjatta Anttila, Kristiina Mäenpää-Liukko, Maija-Liisa Rantala, Hilkka Rautiainen, Werner F. Sommer & Ellen Mommers. (2011) Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. The European Journal of Contraception & Reproductive Health Care 16:6, pages 444-457.
Read now
Mandana Rad, Cornelis Kluft, Marieke L. de Kam, Piet Meijer, Adam F. Cohen, Gary S. Grubb, Ginger D. Constantine & Jacobus Burggraaf. (2011) Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use. The European Journal of Contraception & Reproductive Health Care 16:2, pages 85-94.
Read now
Marie-Hélène Massicotte, Fabienne Langlois & Jean-Patrice Baillargeon. (2010) Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 5:1, pages 77-91.
Read now
Inka Wiegratz & Herbert Kuhl. (2007) High estrogenic impact on the liver by transdermal contraceptive patch. Expert Review of Obstetrics & Gynecology 2:1, pages 15-18.
Read now
Francisca Martínez & Angels Avecilla. (2007) Combined hormonal contraception and venous thromboembolism. The European Journal of Contraception & Reproductive Health Care 12:2, pages 97-106.
Read now
Marie Hofling, Kjell Carlström, Gunilla Svane, Edward Azavedo, Helenius Kloosterboer & Bo Von Schoultz. (2005) Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels – an association with mammographic density. Gynecological Endocrinology 20:2, pages 110-115.
Read now
Karin Hedenmalm, Eva Samuelsson & Olav Spigset. (2004) Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome. Acta Obstetricia et Gynecologica Scandinavica 83:6, pages 576-585.
Read now
U. Pripp, K. Schenck-Gustafsson, B.-M. Landgren & K. Carlström. (2004) Circulating concentrations of hemostatic factors and two "steroid sensitive proteins" during oral hormone replacement therapy in women with coronary heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 64:7, pages 659-666.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.